HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Hariharan Selected Research

Biological Products

8/2007Assessment of the biological and pharmacological effects of the alpha nu beta3 and alpha nu beta5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Hariharan Research Topics

Disease

4Renal Cell Carcinoma (Grawitz Tumor)
08/2021 - 06/2014
3Neoplasms (Cancer)
02/2009 - 10/2000
2Virus Diseases (Viral Diseases)
04/2015 - 08/2009
2Anemia
08/2009 - 06/2000
1Bronchopulmonary Dysplasia
11/2016
1Sepsis (Septicemia)
01/2013
1Birth Weight (Birth Weights)
01/2013
1Neutropenia
08/2009
1Coma (Comas)
03/2009
1Nausea
02/2009
1Anorexia
02/2009
1Fatigue
02/2009
1Nephritis
02/2006
1Congenital Heart Defects (Congenital Heart Defect)
08/2005
1Brain Neoplasms (Brain Tumor)
12/2004
1Sporadic Creutzfeldt-Jakob Disease
02/2004
1Kidney Diseases (Kidney Disease)
12/2001
1Hydronephrosis
11/2001
1Infections
04/2001
1Drug-Related Side Effects and Adverse Reactions
06/2000
1Hemolysis
06/2000
1Hemorrhage
06/2000
1Avitaminosis (Vitamin Deficiency)
06/2000
1Parvoviridae Infections (Parvovirus Infection)
06/2000
1Delayed Graft Function
03/2000

Drug/Important Bio-Agent (IBA)

4Sunitinib (Sutent)FDA Link
08/2021 - 06/2014
3Axitinib (AG 013736)IBA
08/2021 - 06/2014
3Tacrolimus (Prograf)FDA LinkGeneric
08/2009 - 03/2000
2avelumabIBA
08/2021 - 01/2021
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2001 - 03/2000
1Oxygen (Dioxygen)IBA
11/2016
1Neutralizing AntibodiesIBA
04/2015
1Sorafenib (BAY 43-9006)FDA Link
06/2014
1CytokinesIBA
06/2014
1LipidsIBA
08/2009
1tofacitinibIBA
08/2009
1BilirubinIBA
02/2009
1(5- fluoro- 2- methyl- 1- (4- pyridyl)methylene- 3- (N- benzyl)- indene)- acetamide hydrochlorideIBA
02/2009
1Antineoplastic Agents (Antineoplastics)IBA
02/2009
1CilengitideIBA
08/2007
1integrin beta5IBA
08/2007
1Angiogenesis InhibitorsIBA
08/2007
1Integrin alpha ChainsIBA
08/2007
1Biological ProductsIBA
08/2007
1Cidofovir (Vistide)FDA Link
02/2006
1Leflunomide (Arava)FDA LinkGeneric
02/2006
1Antiviral Agents (Antivirals)IBA
02/2006
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2004
114-3-3 Proteins (14-3-3 Protein)IBA
02/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2001
1Contrast MediaIBA
11/2001
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2001
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
10/2000
1IronIBA
06/2000
1Intravenous Immunoglobulins (IVIG)FDA Link
06/2000

Therapy/Procedure

4Therapeutics
06/2014 - 03/2000
3Kidney Transplantation
02/2006 - 03/2000
2Length of Stay
01/2013 - 03/2009
2Transplantation
04/2001 - 03/2000
1Tracheostomy
03/2009
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
08/2005
1Blood Transfusion (Blood Transfusions)
06/2000
1Organ Transplantation
06/2000